Pharmaceuticals: Major
Italian companies operating in the same pharmaceuticals: major industry
The table below has Italian companies that operate under the same industry, pharmaceuticals: major. This list helps you analyze each company’s performance, income statements, and stock activity — all in one place. Sort by key metrics to find the most expensive stocks like Eli Lilly and Company, or spot the most traded options, such as Recordati S.p.A.. Ideal for investors and traders looking to build or refine a strategy within this growing tech segment.
Symbol | Mkt cap | Price | Chg % | Vol | Rel vol | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst rating |
|---|---|---|---|---|---|---|---|---|---|---|---|
 4LLYEli Lilly and Company | 967.17 B EUR | 1,051.2 EUR | +3.06% | 0 | 0.00 | 40.79 | 25.77 EUR | +101.28% | 0.54% | Health technology | Buy |
| 1LLYEli Lilly and Company | 967.17 B EUR | 1,066.0 EUR | +1.47% | 102 | 0.18 | 41.37 | 25.77 EUR | +101.28% | 0.54% | Health technology | Buy |
 4JNJJohnson & Johnson | 541.34 B EUR | 225.20 EUR | +1.58% | 9 | 2.73 | 29.81 | 7.55 EUR | −4.82% | 2.02% | Health technology | Buy |
| 1JNJJohnson & Johnson | 541.34 B EUR | 225.25 EUR | +1.40% | 176 | 0.80 | 29.82 | 7.55 EUR | −4.82% | 2.02% | Health technology | Buy |
 1ABBVAbbVie, Inc. | 376.74 B EUR | 212.7 EUR | +0.76% | 91 | 2.01 | 68.68 | 3.10 EUR | +73.61% | 2.78% | Health technology | Buy |
| 4ABBVAbbVie, Inc. | 376.74 B EUR | 212.6 EUR | +0.71% | 10 | — | 68.65 | 3.10 EUR | +73.61% | 2.78% | Health technology | Buy |
 1ROGRoche Holding Ltd | 313.1 B EUR | 398.00 EUR | +2.41% | 52 | 1.25 | 23.97 | 16.60 EUR | +32.10% | 2.67% | Health technology | Buy |
| 1RORoche Holding Ltd | 313.1 B EUR | 402.2 EUR | −0.05% | 22 | 0.40 | 24.23 | 16.60 EUR | +32.10% | 2.90% | Health technology | Buy |
 1MRKXMerck & Co., Inc. | 275.17 B EUR | 113.34 EUR | +0.89% | 10 | 0.09 | 103.46 | 1.10 EUR | −80.10% | 2.61% | Health technology | Buy |
| 4MRKXMerck & Co., Inc. | 275.17 B EUR | 112.64 EUR | +1.92% | 3 | 0.31 | 102.82 | 1.10 EUR | −80.10% | 2.61% | Health technology | Buy |
 1NOVNNovartis AG | 246.6 B EUR | 135.60 EUR | −0.03% | 1.39 K | 0.31 | 23.81 | 5.69 EUR | −10.40% | 2.94% | Health technology | Neutral |
 1PFEPfizer Inc. | 132.16 B EUR | 23.290 EUR | −0.56% | 3.1 K | 0.46 | 35.22 | 0.66 EUR | −58.56% | 6.43% | Health technology | Neutral |
| 4PFEPfizer Inc. | 132.16 B EUR | 23.420 EUR | +2.54% | 0 | 0.00 | 35.42 | 0.66 EUR | −58.56% | 6.43% | Health technology | Neutral |
 1BMYBristol-Myers Squibb Company | 114.56 B EUR | 56.17 EUR | +0.90% | 53 | 0.15 | 14.13 | 3.97 EUR | +88.93% | 3.88% | Health technology | Buy |
| 4BMYBristol-Myers Squibb Company | 114.56 B EUR | 56.16 EUR | +0.90% | 0 | — | 14.13 | 3.97 EUR | +88.93% | 3.88% | Health technology | Buy |
 4VRTXVertex Pharmaceuticals Incorporated | 108.95 B EUR | 453.20 EUR | +7.08% | 5 | — | 30.11 | 15.05 EUR | +26.73% | 0.00% | Health technology | Buy |
| 1VRTXVertex Pharmaceuticals Incorporated | 108.95 B EUR | 459.40 EUR | +8.53% | 86 | 8.27 | 30.52 | 15.05 EUR | +26.73% | 0.00% | Health technology | Buy |
 4SANSanofi SA | 90.34 B EUR | 75.43 EUR | +0.15% | 200 | 1.48 | 22.66 | 3.33 EUR | −35.60% | 5.47% | Health technology | Buy |
| 1SANSanofi SA | 90.34 B EUR | 75.46 EUR | −0.11% | 1.46 K | 0.29 | 22.67 | 3.33 EUR | −35.60% | 5.47% | Health technology | Buy |
 4REGNRegeneron Pharmaceuticals, Inc. | 69.97 B EUR | 689.9 EUR | +2.51% | 0 | — | 19.47 | 35.43 EUR | +5.16% | 0.46% | Health technology | Buy |
| 1REGNRegeneron Pharmaceuticals, Inc. | 69.97 B EUR | 689.0 EUR | +2.36% | 7 | 0.68 | 19.45 | 35.43 EUR | +5.16% | 0.46% | Health technology | Buy |
 1MRKMerck KGaA | 62.46 B EUR | 143.10 EUR | +0.18% | 3 | 0.03 | 26.25 | 5.45 EUR | −17.22% | 1.53% | Health technology | Buy |
| 4MRKMerck KGaA | 62.46 B EUR | 143.05 EUR | +0.18% | 0 | — | 26.24 | 5.45 EUR | −17.22% | 1.53% | Health technology | Buy |
 1BAYNBayer AG | 48.93 B EUR | 48.60 EUR | −1.26% | 4.9 K | 0.20 | — | −2.19 EUR | +33.72% | 0.22% | Health technology | Buy |
| 4BAYNBayer AG | 48.93 B EUR | 49.33 EUR | +0.37% | 10 | 0.14 | — | −2.19 EUR | +33.72% | 0.22% | Health technology | Buy |
 1GALDGalderma Group AG | 45.22 B EUR | 183 EUR | −6.63% | 0 | — | 58.18 | 3.15 EUR | +113.32% | 0.19% | Health technology | Buy |
 4UCBUCB S.A. | 42.39 B EUR | 225.6 EUR | +0.49% | 0 | — | 19.95 | 11.31 EUR | +64.98% | 0.45% | Health technology | Strong buy |
 4BIIBBiogen Inc. | 26.62 B EUR | 180.16 EUR | +1.72% | 0 | — | 36.44 | 4.94 EUR | −44.28% | 0.00% | Health technology | Buy |
| 1BIIBBiogen Inc. | 26.62 B EUR | 180.06 EUR | +1.64% | 0 | 0.00 | 36.42 | 4.94 EUR | −44.28% | 0.00% | Health technology | Buy |
 1ZTSZoetis, Inc. Class A | 26.02 B EUR | 64.74 EUR | +2.37% | 77 | 0.15 | 12.16 | 5.32 EUR | +7.88% | 2.88% | Health technology | Buy |
| 4ZTSZoetis, Inc. Class A | 26.02 B EUR | 62.98 EUR | −3.32% | 0 | 0.00 | 11.83 | 5.32 EUR | +7.88% | 2.88% | Health technology | Buy |
 1ALNYAlnylam Pharmaceuticals, Inc | 25.42 B EUR | 189.00 EUR | +1.42% | 170 | 0.38 | 36.44 | 5.19 EUR | — | 0.00% | Health technology | Buy |
 1INSMInsmed Incorporated | 24.81 B EUR | 115.84 EUR | +0.29% | 14 | 1.31 | — | −3.59 EUR | +25.76% | 0.00% | Health technology | Strong buy |
 1INCYIncyte Corporation | 21.17 B EUR | 105.95 EUR | +1.83% | 131 | 3.99 | 15.42 | 6.87 EUR | +83.99% | 0.00% | Health technology | Buy |
| 4INCYIncyte Corporation | 21.17 B EUR | 105.90 EUR | +1.78% | 0 | 0.00 | 15.41 | 6.87 EUR | +83.99% | 0.00% | Health technology | Buy |
 4VTRSViatris, Inc. | 16.35 B EUR | 14.090 EUR | −2.00% | 0 | 0.00 | — | −0.31 EUR | +87.33% | 2.92% | Health technology | Buy |
| 1VTRSViatris, Inc. | 16.35 B EUR | 14.092 EUR | −2.08% | 157 | 0.49 | — | −0.31 EUR | +87.33% | 2.92% | Health technology | Buy |
 1JAZZJazz Pharmaceuticals Public Limited Company | 14.43 B EUR | 223.1 EUR | +0.04% | 0 | 0.00 | 17.57 | 12.70 EUR | — | 0.00% | Health technology | Buy |
 1SOBISwedish Orphan Biovitrum AB | 14.21 B EUR | 42.96 EUR | −0.32% | 0 | — | 124.09 | 0.35 EUR | −69.23% | 0.00% | Health technology | Buy |
 1EXELExelixis, Inc. | 11.61 B EUR | 45.990 EUR | −0.03% | 0 | 0.00 | 16.50 | 2.79 EUR | +57.50% | 0.00% | Health technology | Buy |
 4ORNBVOrion Oyj Class B | 11.45 B EUR | 79.00 EUR | −3.19% | 0 | — | 18.94 | 4.17 EUR | +55.11% | 2.11% | Health technology | Neutral |
| 1ORNBVOrion Oyj Class B | 11.45 B EUR | 78.90 EUR | −4.65% | 0 | — | 18.91 | 4.17 EUR | +55.11% | 2.11% | Health technology | Neutral |
 RECRecordati S.p.A. | 10.99 B EUR | 52.85 EUR | +0.38% | 22.07 K | 0.07 | 22.21 | 2.38 EUR | +22.24% | 2.52% | Health technology | Buy |
 1CORTCorcept Therapeutics Incorporated. | 10.38 B EUR | 99.00 EUR | +4.92% | 20 | 0.26 | 270.04 | 0.37 EUR | −61.57% | 0.00% | Health technology | Buy |
 1MDGLMadrigal Pharmaceuticals, Inc. | 10.21 B EUR | 446.9 EUR | +0.90% | 0 | 0.00 | — | −11.28 EUR | −3.44% | 0.00% | Health technology | Strong buy |
 1CYTKCytokinetics, Incorporated | 9.25 B EUR | 66.28 EUR | +0.21% | 0 | 0.00 | — | −6.32 EUR | −45.47% | 0.00% | Health technology | Strong buy |
 1IONSIonis Pharmaceuticals, Inc. | 8.14 B EUR | 49.70 EUR | +4.24% | 0 | 0.00 | — | −3.04 EUR | −93.45% | 0.00% | Health technology | Buy |
 1RGENRepligen Corporation | 8.01 B EUR | 141.00 EUR | +0.04% | 0 | 0.00 | 219.48 | 0.64 EUR | — | 0.00% | Health technology | Strong buy |
 1TGTXTG Therapeutics, Inc. | 6.6 B EUR | 43.5 EUR | +2.59% | 5 | 0.30 | 18.09 | 2.40 EUR | +656.78% | 0.00% | Health technology | Strong buy |
 4GRFGrifols, S.A. Class A | 6.08 B EUR | 10.020 EUR | −1.23% | 0 | — | 15.07 | 0.66 EUR | +51.93% | 1.85% | Health technology | Buy |
| 1GRFGrifols, S.A. Class A | 6.08 B EUR | 10.095 EUR | −1.85% | 0 | 0.00 | 15.19 | 0.66 EUR | +51.93% | 1.85% | Health technology | Buy |
 1VKTXViking Therapeutics, Inc. | 3.46 B EUR | 29.90 EUR | +3.82% | 0 | 0.00 | — | −4.08 EUR | −213.33% | 0.00% | Health technology | Strong buy |
 4OGNOrganon & Co. | 3.09 B EUR | 11.784 EUR | +0.48% | 0 | 0.00 | 17.24 | 0.68 EUR | −70.09% | 0.59% | Health technology | Neutral |
| 1OGNOrganon & Co. | 3.09 B EUR | 11.788 EUR | +0.53% | 25 | 1.94 | 17.25 | 0.68 EUR | −70.09% | 0.59% | Health technology | Neutral |
 1ROVILaboratorios Farmaceuticos Rovi, S.A. | 2.95 B EUR | 58.95 EUR | −0.76% | 0 | — | 16.28 | 3.62 EUR | +39.34% | 1.33% | Health technology | Buy |
 1SRPTSarepta Therapeutics, Inc. | 1.54 B EUR | 14.42 EUR | 0.00% | 100 | 0.06 | — | −2.54 EUR | −293.97% | 0.00% | Health technology | Neutral |
 PHILPhilogen SpA | 695.98 M EUR | 23.80 EUR | −1.04% | 16.14 K | 0.93 | 4.18 | 5.70 EUR | +407.11% | 2.94% | Health technology | Strong buy |
 FFFine Foods & Pharmaceuticals N.T.M. SpA | 200.92 M EUR | 8.40 EUR | +1.20% | 8.66 K | 0.40 | 29.82 | 0.28 EUR | −26.43% | 1.95% | Health technology | Buy |
 4IPHInnate Pharma SA Class A | 141.61 M EUR | 1.816 EUR | +0.44% | 162 | — | — | −0.54 EUR | +11.11% | 0.00% | Health technology | Buy |